RxDoctor Payments Data

Sharon Nachman

Pediatric Infectious Diseases · Stony Brook, NYNPI 1700828886

Payments from drug & device makers

What this record shows

That places this record below the midpoint for pediatric infectious diseases clinicians in NY, where the typical reported total is $248.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$47,622,858in research payments, 2019–2025

Across 454 payments — averaging $104,896 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Viiv Healthcare Company$34.9M
  • Modernatx, Inc.$2.9M
  • GSK$2.8M
  • Gilead$2.3M
  • Merck$2.3M
  • Pfizer$2.2M
  • plus $151K from 2 others

How this compares

$0 in reported general payments places this provider in the 10th percentile of 73 pediatric infectious diseases providers in New York.

See all pediatric infectious diseases providers in New York →

Other pediatric infectious diseases in Stony Brook

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →